Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series.
Aoki H, Matsumoto N, Takahashi H, Honda M, Kaneko T, Arima S, Ishii T, Mizutani T, Masuzaki R, Nirei K, Yamagami H, Ogawa M, Kanda T, Moriyama M, Miura K.
Aoki H, et al. Among authors: arima s.
Anticancer Res. 2021 Dec;41(12):6225-6230. doi: 10.21873/anticanres.15442.
Anticancer Res. 2021.
PMID: 34848477